Follow DRNO on...
KantarHealth is expanding its CardioMonitor service into Japan and China, a major step towards its goal of providing a globally consistent cardiovascular and diabetes patient database. More
In the US, KantarHealth Joint CEO Elaine Riddell has decided to leave the company to 'pursue other opportunities': Joint CEO Lynnette Cooke assumes sole global CEO responsibilities with immediate effect. More
Pharma and biotech specialist MattsonJack has launched a study that focuses on specific cancer tumor types in China. More
Pharma and biotech specialist MattsonJack has introduced CancerNFluence – an online database of peer-nominated physicians who influence cancer treatment decisions. More
Pharma and biotech specialist MattsonJack has rolled out its web-accessible epidemiology database in the emerging markets of Brazil, the Russian Federation, India and China. More
Pharma and biotech specialist MattsonJack has appointed Thierry Devevey as Director, Europe, based in the group's Paris office. More
Kantar-owned pharma and biotech research firm MattsonJack has formed a 'co-operative agreement' with LifeScience Consulting Group (LCG), based in Karlsruhe, Germany. LCG becomes the firm's associate partner conducting research in the German-speaking countries. More
Kantar-owned pharma and biotech research consultancy MattsonJack has appointed Dr Pierre Anhoury as Senior Vice President and Business Leader, to support the expansion of the firm's cancer and non-cancer qual and quant services in Europe. More
In the US, Pharma and biotech research specialist The Mattson Jack Group, has released its Comorbidity Database to help clients make decisions based on an in-depth understanding of any combination of medical disorders or diagnostic categories. More
Kantar-owned pharma / biotech consultancy Mattson Jack Group has released a new syndicated study to help with decisions surrounding commercial opportunities in the field of oncology. More
Saint Louis-based pharma and biotech research consultancy MattsonJack has promoted Dr Amit Dhawan to the role of Medical Director, where he will build on his experience in clinical medicine, new product analysis, epidemiology, and market trend forecasting. More
US-based pharmaceutical and biotech specialist the Mattson Jack Group (MJG) has appointed Eric John as VP and Bernadete Piassa as Senior Project Director to its MR team. As a result of the expansion, MJG says it is planning to create 'a number of unique products' and expand its segmentation and modelling services. More
US-based Mattson Jack Group (MJG), owned by WPP, has appointed three new members of staff for its Advanced Methods Group as the company plans to enhance its MR offerings. William Serad, Mylinda Willsey and Henry Lu will be based in MJG's Philadelphia office. More
Register (free) for Daily Research News
REGISTER FOR NEWS EMAILS
To receive (free) news headlines by email, please register online
